FF-10502
| Code | Size | Price |
|---|
| TAR-T39290-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
FF-10502, a structural analog of Gemcitabine, is a pyrimidine nucleoside antimetabolite . FF-10502 inhibits DNA polymerase α and β . FF-10502 shows beneficial anticancer activity via a mechanism of action on dormant cells.
CAS:
184302-49-6
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Shinji Mima, et al. FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells. J Pharmacol Exp Ther. 2018 Jul;366(1):125-135.